Mirum Pharmaceuticals earnings were -$58.6M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest MIRM earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$5.9M, down 60.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MIRM reported annual earnings of -$87.9M, with -46.2% growth.
Mirum Pharmaceuticals Earnings Reports & History FAQ
What were Mirum Pharmaceuticals's earnings last quarter?
On MIRM's earnings call on Invalid Date, Mirum Pharmaceuticals (NASDAQ: MIRM) reported Q2 2025 earnings per share (EPS) of -$0.12, up 76.92% year over year. Total MIRM earnings for the quarter were -$5.86 million. In the same quarter last year, Mirum Pharmaceuticals's earnings per share (EPS) was -$0.52.
Is Mirum Pharmaceuticals profitable or losing money?
As of the last Mirum Pharmaceuticals earnings report, Mirum Pharmaceuticals is currently losing money. Mirum Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$58.56 million, a 46.35% decrease year over year.
What was MIRM's earnings growth in the past year?
As of Mirum Pharmaceuticals's earnings date in Invalid Date, Mirum Pharmaceuticals's earnings has grown year over year. MIRM earnings in the past year totalled -$58.56 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.